Balance Sheet Data

Agios Pharmaceuticals, Inc. (AGIO)

$22.14

+0.02 (+0.09%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 423.94585.30564.88572.931,020.02263.79340.76440.19568.64734.58
Total Cash (%)
Account Receivables 3.8410.4415.3225.4000.010.010.010.010.02
Account Receivables (%)
Inventories -0.877.3314.7000000.010.01
Inventories (%)
Accounts Payable 22.7717.8821.9026.8416.704.335.597.229.3212.05
Accounts Payable (%)
Capital Expenditure -4.63-6.99-12.17-14.91-5.74-1.49-1.92-2.48-3.21-4.14
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.